@ndcar Which location is that?

@yaireinhorn 🤞

@AnjKhem My first trip to China for biotech was 2018. It was eye opening.

@SamDavisEsq Despite their record, the Chiefs did not look great in the first half of the season, but they’ve dialed it up when it counts.

@CEOCorbus Right in this case though part of it is a math problem that is tricky to solve by innovation alone. Scientists in China making $50K vs $200K in Boston.

@xbiodude It was a good idea and ahead of its time, but nobody was buying.

RT @BiotechTVHQ: 𝐁𝐫𝐢𝐠𝐡𝐭 𝐌𝐢𝐧𝐝𝐬: @DanaFarber investigators @DrChoueiri and Patrick Ott describe a personalized cancer vaccine trial in kidney…

RT @TheStalwart: You can tell that the Chinese pharma story is about to get big

RT @DrChoueiri: I enjoyed very much @bradloncar visit to @DanaFarber to discuss our @Nature paper of the Personalized Cancer Vaccine clinic…

@matthewherper @chrissyfarr Men are bigger scammers. See crypto.

@HealthcareNinj1 @Sports_bios Yes

@BowTiedBiotech Generic utilities is sadly a very good description for a lot of these companies lately.

@Sports_bios Through a regulatory loophole, HIMS is making the money today without spending a dime that big pharma would have to spend $7B to be making 4 years from now. Tough business!

@Sports_bios Well said. Surprisingly, seems there was mostly a lack of obesity FOMO in the commentary this week.

RT @JMaraganore: Same story, 14 years and one day later. For the sake of patients, let’s hope for the same outcome! Keep going, CRISPR f…

@LNuzhna Biotech is a physical place - and it is Kendall. The best.

Could $MRK $REGN and $PFE earnings and commentary have been more underwhelming?